Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

NCT01052077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

773

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: OPC-34712
DRUG: Placebo
DRUG: ADT

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.